Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IFNGR2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | TEX13B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | ITGBL1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | CYP3A7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | WDFY4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
mRNA | FCRL5 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
mRNA | GPR68 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | FMNL2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | SYN3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | PALM2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |